|
Market Closed -
Nasdaq
04:00:00 2026-10-20 pm EDT
|
5-day change | 1st Jan Change | ||
| 438.94 USD | +3.29% |
|
+6.32% | +34.11% |
| 05:24am | Barclays Adjusts Price Target on Amgen to $400 From $380 | MT |
| 02:28am | Positive Results for an AstraZeneca and Amgen Product |  |
| Market Cap | 237B 211B 196B 177B 333B 22,481B 339B 2,349B 923B 11,764B 890B 872B 37,530B | P/E 2026 * |
27.9x | P/E 2027 * | 24.9x |
|---|---|---|---|---|---|
| Enterprise Value | 279B 248B 230B 208B 391B 26,398B 398B 2,758B 1,084B 13,815B 1,045B 1,024B 44,071B | EV / Sales 2026 * |
7.15x | EV / Sales 2027 * | 6.76x |
| Free-Float |
99.77% | Yield 2026 * |
2.3% | Yield 2027 * | 2.43% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMGN | Delayed | |
CBOE
| AMGN | Real-time | |
|
Mexican S.E.
| AMGN * | End-of-day quote | |
|
London S.E.
| 0R0T | Delayed | |
|
Tradegate
| AMG | Real-time | |
|
Xetra
| AMG | Delayed | |
|
Boerse Muenchen
| AMG | Real-time | |
|
Börse Stuttgart
| AMG | Delayed | |
|
Borsa Italiana
| 1AMGN | End-of-day quote | |
|
Deutsche Boerse AG
| AMG | Delayed | |
|
Berne S.E.
| 000907582 | End-of-day quote | |
|
Wiener Boerse
| AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGNCL | End-of-day quote | |
|
CBOE
| 0R0T | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Amgen Inc.
| 1 day | +3.29% | ||
| 1 week | +6.32% | ||
| Current month | +4.14% | ||
| 1 month | +13.82% | ||
| 3 months | +20.53% | ||
| 6 months | +25.35% | ||
| Current year | +34.11% |
| 1 week | 424.74 |  | 441.76 |
| 1 month | 396.01 | | 441.76 |
| Current year | 318.21 | | 447.03 |
| 1 year | 288 | | 447.03 |
| 3 years | 249.7 | | 447.03 |
| 5 years | 198.64 | | 447.03 |
| 10 years | 133.64 | | 447.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 2012-04-30 |
| Director of Finance/CFO | 62 | 2010-05-12 | |
Paul Burton
CTO | Chief Tech/Sci/R&D Officer | 57 | 2023-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 2012-12-31 |
Tyler Jacks
BRD | Director/Board Member | 65 | 2011-12-31 |
Robert Eckert
BRD | Director/Board Member | 71 | 2011-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/26 | Other | Chief Financial Officer | 34,061 | 0.0063% | ||
| 8/13/26 | Exercice | Executive/Senior Manager | 3,756 | 0.0007% | ||
| 8/7/26 | Free | Director | 85 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.29% | +6.32% | +44.71% | +57.43% | 237B | |
| +3.49% | +10.04% | +58.68% | +119.56% | 1,144B | |
| +2.19% | +4.32% | +33.88% | +69.52% | 625B | |
| +2.26% | +5.37% | +24.57% | +97.69% | 511B | |
| +0.03% | +5.26% | +39.03% | +64.34% | 377B | |
| +3.25% | +4.45% | +71.80% | +44.44% | 366B | |
| +0.15% | +3.41% | +21.31% | +50.11% | 291B | |
| -0.07% | +2.54% | +1.11% | +24.87% | 262B | |
| +2.25% | +5.81% | +27.13% | +101.17% | 194B | |
| -0.58% | +1.62% | -26.72% | -61.87% | 174B | |
| Average | +0.46% | +5.86% | +29.55% | +56.73% | 418.16B | |
| Weighted average by Cap. | +0.12% | +6.70% | +38.17% | +75.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.97B 34.68B 32.14B 29.13B 54.74B 3,691B 55.66B 386B 152B 1,932B 146B 143B 6,162B | 40.36B 35.92B 33.29B 30.17B 56.69B 3,823B 57.64B 399B 157B 2,001B 151B 148B 6,382B |
| Net income | 8.54B 7.6B 7.05B 6.38B 12B 809B 12.2B 84.54B 33.21B 423B 32.03B 31.37B 1,351B | 9.43B 8.39B 7.78B 7.05B 13.24B 893B 13.46B 93.3B 36.65B 467B 35.36B 34.62B 1,491B |
| Net Debt | 41.36B 36.81B 34.12B 30.92B 58.1B 3,918B 59.07B 409B 161B 2,050B 155B 152B 6,541B | 35.3B 31.42B 29.12B 26.39B 49.6B 3,344B 50.43B 349B 137B 1,750B 132B 130B 5,583B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-20 | $438.94 | +3.29% | 2,217,227 |
| 26-10-19 | $424.94 | -1.75% | 2,682,830 |
| 26-10-16 | $432.49 | -0.35% | 2,567,330 |
| 26-10-15 | $434.03 | +1.86% | 4,625,784 |
| 26-10-14 | $426.11 | +3.21% | 3,085,121 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
Select your edition
All financial news and data tailored to specific country editions
